About the role of bacteria in patients with bronchial asthma, chronic obstructive pulmonary disease and ACOS



Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The article deals with bacterial lung microbiota in patients with bronchial asthma (BA) and chronic obstructive pulmonary disease (COPD), bacterial inflammation of the bronchopulmonary system which can be manifested by sensitization and allergy. Also they can be a trigger with the development of bacterial inflammation. Bacteria can colonize the lungs without severe clinical, laboratory and instrumental changes. High levels of IgG to Str. pneumoniae, Neisseria perflava, Haemophilus influenza in ACOS patients can be evidence of their etiological significance. Taking into account the etiological significance of microbiota, methods of treatment of patients with COPD and BA with the use of antibiotics, vaccines and probiotics have been developed.

Full Text

Restricted Access

About the authors

G B Fedoseev

The M.V. Chernorutsky Department of Hospital Therapy of the Pavlov First State Medical University of St. Petersburg

Email: fedoseevsp@mail.ru

V I Trofimov

The M.V. Chernorutsky Department of Hospital Therapy of the Pavlov First State Medical University of St. Petersburg

V I Golubeva

The M.V. Chernorutsky Department of Hospital Therapy of the Pavlov First State Medical University of St. Petersburg

V G Timchik

The M.V. Chernorutsky Department of Hospital Therapy of the Pavlov First State Medical University of St. Petersburg

K V Negrutsa

The M.V. Chernorutsky Department of Hospital Therapy of the Pavlov First State Medical University of St. Petersburg

T S Razumovskaya

The M.V. Chernorutsky Department of Hospital Therapy of the Pavlov First State Medical University of St. Petersburg

V A Aleksandrin

The M.V. Chernorutsky Department of Hospital Therapy of the Pavlov First State Medical University of St. Petersburg

K N Kryakunov

The M.V. Chernorutsky Department of Hospital Therapy of the Pavlov First State Medical University of St. Petersburg

References

  1. Huang YJ, Nelson CE, Brodie EL, Desantis TZ, Baek MS, Liu J et al. Airway microbiota and bronchial hyperresponsiveness in patients with suboptimally controlled asthma. Allergy Clin Immunol. 2011;127:372-381.
  2. Beck JM, Young VB, Huffnaagle GB. The microbiome of lung. Transl Res. 2012;160:258-266.
  3. Wang L, Hao K, Jang T, Wang C. Role of lung microbiota in the pathogenesis of chronic obstructive pulmonary disease. Chin Med J. (Engl.). 2017;130:21072111.
  4. Lieberman D, Peintz S. Atypical pathogen infection in adults with acute exacerbation of bronchial asthma. Am Respir Crit Care Med. 2003;167:406-410.
  5. Ntwcomb DC. Stokes Peebles IR Bugs and asthma. A different disease? Proc Am Thorac Soc. 2009;6:266-271.
  6. Dickson RP Huffnagle GB. The Lung Microbiome: New Principles for Respiratory in Health and Disease. PLos Pathog. 2015;11:e1004923.
  7. Schmidt A, Belaaouaj A, Bissinger R, Koller G, Malleret L, Orazio C at al. Neutrophil elastase-mediated incrise in airway temperature during inflammation. J Cyst Fibros. 2014;1:623-631.
  8. Dickson RP, Marninez FJ, Huffnagle GB. The role of the microbiome in exacerbations of chronic lung diseases. Lancet. 2014;384:691-702.
  9. Mammen MJ, Sethi S. COPD and microbiome. Respirology. 2016;21:590-599.
  10. Fujimura KE, Lynch SV. Microbiota in allergy and asthma and the emerging relationship with the gut microbiome. Cell Host Microbe. 2015;17:592-602.
  11. Smolinska S, Groeger D, O’Mahony L. Biology of the microbiome: interactions with the host immune response. Gastroenterol Clin N Am. 2017;46:19-35.
  12. O’Dwyer DR, Dickson RP, Moore BB. The lung microbiome, immunity, and the pathogenesis of chronic lung disease. J Immunol. 2016;196:4839-4847.
  13. Abrahamsson TR, Jakobsson HE, Andersson AF, Bjorksten B, Engstrand L, Jenmalm MC. Low gut microbiota diversity in early infancy precedes trend in school age. Clin Exp Allergy. 2014;44:842850.
  14. Liu AN, Leung DIM. Renessance of the hygiene hypothesis. J Allergy Clin Immunol. 2006;117:1063-1066.
  15. Hirsch T, Range U, Walther KU, Haderer B, Lassing S, Frey G, Leupold W Prevalence and determinants of house dust mite allergen in East German homes. Clin Exp Allergy. 1998;28:956-964.
  16. Von Mutius E, Vercelli D. Farm living: effects on childhood asthma and allergy. Nat Rev Immunol. 2010;10:861-868.
  17. Barnes KC. Genetic studies of the etiology of asthma. Proc Am Thorac Soc. 2011;8:143-148.
  18. Blaser MN, Falkow S. What are the consequences of the disappearing human microbiota? Nat Rev Microbiol. 2009;7:887-894.
  19. Mogensen TH. Pathogen recognition and inflammatory signaling in innate immune defenses. Clin Mirobiol Rev. 2009;22:240-273.
  20. Fowler SJ, Tavernier G, Neven R. High blood eosinophil counts predict sputum eosinophilia in patients with severe asthma. J Allergy Clin Immunol. 2015;135:822-824.
  21. Riedel J, Brau-Fehrlander C, Eder W Schreuer M, Waser M, Maisch S et al. Exposure to farming in early life and development of asthma and allergy: a cross-sectional survey. Lancet. 2001;358:1129-1133.
  22. Schaub B, Lauener R, von Mutius E. The many faces of the hygiene hypothesis. J Allergy Clin Immunol. 2006;117:969-977.
  23. Hugg TT, Jaakkola MS, Ruotsalainen R, Pushkarev V, Jaakkola JJ. Exposure to animals and risk of allergic asthma: a population-based cross-sectional study in Finnish and Russian children. Environ Health. 2008;7:28.
  24. Thavagnanam S. A meta-analysis of the association between Caesarean section and childhood asthma. Clin Exp Allergy. 2008;38:629-633.
  25. Ege ML. Exposure to Environmental Microorganisms and Childhood Asthma. N Engl J Med. 2011;364:701-709.
  26. Edwards ML, Bartlett NW, Hussel T Openshaw P, Johnston SL. The microbiology of asthma. Nat Rev Micro. 2012;10:459-471.
  27. Kozlov R et al. disease in Central and Eastern Europe, and Israel. Cent Eur J Health. 2012;20:121-125.
  28. Jackson ML, Nelson JC, Jackson LA. Risck factors for community-acquired pneumonia in immunocompetent seniors. J A Geriatr Soc. 2009;57:882-888.
  29. Juthani-Mehta M, De RN, Allor H, Chen S, O’Leary JR, Bauer DC et al. Modifiable risk factors for pneumonia requiring hospitalization of community-dwelling older adults: the Health, Aging, and Body Composition Study. J Am Geriatr Soc. 2013;61:1111-1118.
  30. Gau JT, Acharya U., Khan S., Heh V., Mody L., Kao TC. Pharmacotherapy and the risk for community-acquired pneumonia. BMC Geriatr. 2010;10. doi: 10.1186/1471-2318-10-45.
  31. Inghammar M., Engstrom G., Kahlmeter G., Ljungberg B., Lofdahl CG, Egtsten A. Invasive pneumococcal disease underlying pulmonary disorder. Clin Microbiol Infect. 2013;19:1148-1154.
  32. Булатов П.К. Бронхиальная астма. Медицина. 1964:325
  33. Адо АД, Булатов П.К. Клинико-физиологические основы классификации бронхиальной астмы. Материалы V. межобл. научн. конф. терапевтов «Этиология, патогенез, клиника и лечение заболеваний органов дыхания». Л., 1969:258-265
  34. Адо А.Д. Современные проблемы аллергических реакций. Вестн. АМН СССР. 1979;1:34-43
  35. Адо АД, Федосеева В.Н. Роль нейссерий в этиологии и патогенезе бронхиальной астмы. Клин вед. 1980;4:24-28
  36. Scottish Intercollegiate Guidelines Network and British Thoracic Society (2014) British the management of asthma. Thorax 69 Suppl 1, il-i195.
  37. Dulek DE, Peebles RS. Bacteria and asthma: more there than we thought. Expert Rev Respir Med. 2911;5:329-332.
  38. Marri PR, Stern DA, Wright AL, Billheimer D., Martinez FD. Asthma-associated differ microbial composition of induced sputum. J. Allergy Clin Immunol. 2013;131:346-352.
  39. Rogers GB, Shaw D., March RL, Carroll ML, Serisier DJ, Brucce KD. Respiratory microbiota: addressing clinical questions, informing clinical practice. Thorax. 2015;70:74-81.
  40. Han MK. Significance of the microbiome in obstructive lung disease. Thorax. 2012;67:436-463.
  41. Arman J., von Mutius E. Do bacteria have role in asthma development. Eur Resp J. 2010;36:469-471.
  42. Green BJ. Potentially pathogic airway bacteria and neutrophilic inflammation in treatmеnt resistant severe asthma. PLoS ONE. 2014;9:t100645.
  43. Simpson JL, Dali J., Baines KL, Yang IA, Upham IW, Reynolds PN et al. Hemophilis influenza and Tropheryma in poorly controlled asthma. Eur Resp J. 2016;47:792-800.
  44. Earl CS, Keong, Shi-qi An, Murdoch S., McCarthy, Garmendia J. et al. Haemophilus influenzae responds to glucocorticoids used in asthma therapy by modulation of biofilm formation and antibiotic resistance. EMBO Mol Med. 2010;7:1018-1033. 4 5. Guilbert TW, Denlinger LC. Role of infection in the development and exacerbation of asthma. Expert Rev Respir Med. 2010;4:71-83.
  45. Joung JJ. Risk for infection in patients with asthma (or other atopic condition): Is asthma more than a chronic airway disease? J. Allergy Clin Immunol. 2014;134:247-257.
  46. Nisar N., Guleria R., Kumar S. Mycoplasma pneumoniae and its role in asthma. Postgrad Med J. 2007;83:100-104.
  47. Korppi M. Management of bacterial infections in children with asthma. Expert Rev Anti Infect Ther. 2009;7:869-877.
  48. Iikura M., Hojo M., Koketsu R., Watanabe S., Sato A., Chino H. et al. The importance of bacterial and viral infections associated with adult asthma exacerbations in clinical practice. PLOS One. 2015;10(4):e0123584. Published online 2015 Apr
  49. DOI: 10/1371/journal.pone. 0123584.
  50. Harju TH, Leinonen M., Nokso-Koivisto J., Korhonen T., Raty R., He Q. et al. Pathogenic bacteria and viruses in induced sputum or pharyngeal secretions of adults with stable asthma. Thorax. 2006;61:579-584.
  51. Huang YJ, Nariya S., Harris YM, Lynch SV, Choy DF, Arron YR, Boushey H. The Airway Microbiome in Severe Asthma: Associations with Disease Features and Severity. J. Allergy Clin Immunol. 2015;136:874-884.
  52. Hahn DL. Infections asthma: a reemerging clinical entity? J. Fam Pract. 1995;41:153-157.
  53. Halablab MA, Hijazi SM, Fawzi MA, Ara GF. Staphylococcus aureus nasal carriage rate and associated risk factors in individuals in community. Epidemiol Infection. 2010;138:702-706.
  54. Jackson DJ, Tern JE, Lemanske RF. The contributions of allergic sensitization and respiratory pathogens to asthma inception. Allergy Clin Immunol. 2016;137:659-665.
  55. Корчева ЕГ, Печкуров Д.В. Особенности бронхиальной астмы у детей при бактериальной контаминации верхних дыхательных путей. Прaкт медицина. 2011;5(11)
  56. Novak N., Bieber T. Allergic and nonallergic forms of atopic diseases. J. Allergy Clin Immunol. 2003;112:252-262.
  57. Hilty M., Burke C., Pedro H., Cardenas P., Bush A., Bossley C. et al. Disordered microbial communities in asthmatic airways. PLos One. 2015;5(1):е8578. doi: 10.1371/journal. pone.0008578.
  58. Huang Y., Sethi S., Murphy T., Nariya S., Boush HA, Lynch SV. Airway Microbiome Dynamics in Exacerbations of Chronic Obstructive Pulmonary Disease. J. Clin Microbiol. 2014;52:2813-2823.
  59. Bisgaard H., Hermansen MN, Buchvald F., Loland L., Halkjaer LB, Bonnelykke K. et al. Childhood asthma after bacterial colonization of the airway in neonates. N. Engl J. Med. 2007;357:1487-1495.
  60. Larsen JM, Brix S., Thysen AH, Birch S., Rasmussen MA, Bisgaard H. Children with asthma by school age display aberrant immune responses to pathogenic airway bacteria as infants. J. Allergy Clin Immunol. 2014;133:1008-1013.
  61. Brikey WJ Alexis NE, Hernander ML, Reed W., Ting JP, Peden DB. Sputum inflammatory cells from persons with allergic rhinitis and asthma have decreased inflammasome gene expression. J. Allergy Clin Immunol. 2011; 128(4):900-903. doi: 10.1016/j.jaci.2011.08.012/.
  62. Zhang Q., Illing R., Hyi CK, Downey K., Carr D., Stearn M. et al. Bacteria in sputum of stable severe asthma and increased airway wall thickness. Respiratory Research. 2012;13:35-39.
  63. Walk P., Tooze M., Powell H., Parsons K. Viral and bacterial infection in acute asthma and chronic obstructive pulmonary disease increases the risk of readmission. Respirology. 2013. DOI: 10.1111resp. 12099.
  64. Juhn I. Risks for infection in patients with asthma (or other atopic conditions): Is asthma more than a chronic airway disease? J. Allergy Clin Immunol. 2014;134:247-257.
  65. Федосеева ВН, Молотилов БА, Ларина ОН, Федоскова Т.Г. Бактериальная аллергия. Пенза. 2004:213
  66. Федосеев ГБ, Трофимов ВИ, Ровкина ЕИ и соавт. Бронхиальная астма и инфекция: диагностика и принципы лечения. Пульмонология. 2008;5:86-94
  67. Durack J., Lynch, Nriya S., Bhakta NR, Beigelman A., Castro et al. Features of the bronchial bacterial microbiome associated with atopy, asthma, and responsiveness to inhaled corticosteroid treatment. J. Allergy Clin Immunol. 2017;140:63-75. DOI: 10.101.1016/j.jaci/2016.08.055.
  68. Bachert C., van Steen K., Zhang N., Holtappels G., Cattaert T., Maus B. et al. Specific IgE against Staphylococcus aureus enterotoxins: an indepenponsivenesdent risk factor for asthma. J. Allergy Clin Immunol. 2012;130:376-381.
  69. Foster TJ. Immune evasion by staphylococci. Nat Rev Microbiol. 2005;3:948-958.
  70. Chavakis T., Hissain M., Kanse SM, Peters G., Bretzel RG, Flock JI et al. Staphylococcus aureus extracellular adherence protein serves as anti-inflammatory factor by inhibiting the recruitment of host leukocytes. Nat Med. 2002;8:687-693.
  71. Maresso AW, Schneewind O. Iron acquisition and transport in Staphylococcus aureus. Biometals. 2006;19:193-203.
  72. Regev-Yochay G., Trzcinski K., Thompson C., Malley R., Lipsitch M. et al. Interference between Streptococcus pneumoniae and Staphylococcus aureus: In vitro hydrogen peroxide-mediated killing by Streptococcus pneumoniae. J. Bacteriol. 2006;188:4996-5001.
  73. Anto JM, Pinart M, Akdis M, Auffray C, Bachert C, Basagara X et al. Understanding the complexity of IgE-related phenotypes from childhood to yong adulthood: mechanisms of the development of allergy (MeDALL) seminar. J Allergy Clin Immunol. 2012;129:943-954.
  74. Benoit M., Desnues B., Mege JL. Macrophage polarization in bacterial infection. J. Immunol. 2008;181:3733-3739.
  75. Price L., Graham KJ, Connolly J., Anwar S., Ridley R., Sabroe I. et al. Staphylococcus aureus induced eosinophil cell death mediated by alfa-hemolysin. Plos One. 2012;7(2):е31506. DOI: 10.1371./journal.pone.0031506.
  76. Bachert C., Gevaert P., Holtappels G., Holtappels G., van Cauwenberge P., Johansson SG. IgE to Staphylococcus aureus enterotoxins in serum is related to severity of asthma. J. Allergy Clin Immunol. 2003;111:1131-1132.
  77. Hermann I., Rath S., Ziesemer S., Volksdorf T., Dress RJ, Gutjahr M. et al. Staphylococcus aureus Hemolysin A diprupts cell-matrix adhesions in human airway epithelial cells. Amer J. Respir Cell Mol Biol. 2015;52:14-24.
  78. Torrent M., De la Torre BG, Nogues MV, Andreu D., Boix E. Bactericidal and membrane disruption activities of the eosinophil cationic protein and largely retained in an N-terminal fragment. Biochem J. 2009;421:425-434. doi: 10.1042/BJ20082330.
  79. Hentschke I., Graser A., Melichan VO, Kiefer A., Zimmermann T., Kros B. et al. IL-33/ST2 immune response to respiratory bacteria in pediatric asthma. Sci Reports. 2017;7:43426. doi: 10.1038/srep43426.
  80. Hardt WD. Antibiotics: Homed to the hideout. Nature. 2015;527:309-310. DOI: 10ю 1038/nature 15647.
  81. Wood-Jung Song, Eun-Jung Jo, Ji-Won Lee, Hye-Ryun K., Sang-Heon Cho, Kyung-Up Min, Yoon-Seok Chang. Staphylococcal enterotoxin specific IgE and asthma: a systematic review. Asia Pac Allergy. 2013;3:120-126.
  82. Corriveau MN, Zhang N., Holtappels G., Van Roy N., Bachert C. Detection of Staphylococcus aureus in nasal tissue with peptide nucleic acid-fluorescence in situ hybridization. Am J. Rhinol Allergy. 2009;3:461-465. doi: 10.2500/ajra.2009.23.3367.
  83. Deryke L., Perez-Novo C., Van Crombruggen K., Corriveau MN, Bachen C. Staphylococcus aureus and chronic airway disease. World Allergy Organ J. 2010;3:223-228.
  84. Harvey RL, Wallwork BD, Lund VJ. Anti-inflammatory effect of macrolides: Applications in chronic rhinosinusitis. Immunol Allergy Clin North Am. 2009;3:689-703.
  85. Sethi S., Murphy TF. Bacterial infection in chronic obstructive pulmonary disease in 2000: a state-of-the-Art Review. Clin Microbiol Rev. 2001;14:336-363.
  86. Pauwels R., Verschraeger R., van der Straeter M. IgE antibodies to bacteria in patients with bronchial asthma. Allergy. 1980;35:665-669.
  87. Ishrag AA. Study Specific Immunoglobulin E.G. and Bacterial which induced Asthmatics. J. Natur Sci Res. 2015;5:21-25.
  88. Hales BJ, Martin AS, Pearce IJ, Rueter K., Zhang G., Khoo SK et al. Anti-bacterial IgE in the antibody responses of house dust mite allergic children. Clin Exp Allergy. 2009;39:1170-1178. doi: 10.1111/j.1365-2222.2009.03252x.
  89. Bachert C., Zhang N., Holtappels G., De Lobel L., van Cauwenberge P., Liu et al. Presence of IL-5 protein and IgE antibodies to staphylococcal enterotoxins in nasal polyps is associated with comorbid asthma. J. Allergy Clin Immunol. 2010;126:962-968. doi: 10.1016/j.yaci.2010.07.007.
  90. Kim SH, Yang SY, You J., Le SB, You J., Chang YS et al. Association of specific immunoglobulin E. to Staphylococcal enterotoxin with airway hyperresponsivenes in asthma patients. Tuberc Respir Dis. 2016;79:295-301.
  91. Hales B., Chai L., Elliot CE, Pearce LJ, Zhag G., Heinric TK et al. Antibacterial antibody responses associated with the development of asthma in house dust mite-sensitised and nonsensitised children. Thorax. 2012;67:321-327. DOI: 10.1136. thoraxjnl-2011-200650.
  92. Louis R., Djukanovic R. Is the neutrophil a worthy target in severe asthma and chronic obstructive pulmonary disease? Clin Exp Allergy. 2006;36:563-567.
  93. Dworski R., Simon HU, Hoskins A., Yousefi S. Eosinophil and neutrophil extracellular DNA traps in human allergic asthmatic airways. J. Allergy Clin Immunol. 2011;127:1260-1266.
  94. Simpson JL, Grissel TV, Douwes J., Scott RJ, Boyle MJ, Gibson PG. Innate immune activation in neutrophilic asthma and bronchiectasis. Thorax. 2007;62:211-218.
  95. Pham DL, Ban GY, Kim SH, Shin YS, Ye YM, Chwae YJ, Park HS. Neutrophil autophagy and extracellular DNA traps cjntribute to airway inflammation in severe asthma. Clin Exp Allergy. 2017;47:57-70. doi: 10.1111/cea.12859.
  96. Федосеев ГБ, Коровина ОВ, Тенигина НГ Комплексная диагностика различных клинико-патогенетических вариантов бронхиальной астмы. Тер Арх. 1977;6:51-55
  97. Федосеев ГБ, Хлопотова Г.П. Бронхиальная астма. Л., «Медицина». 1988:269
  98. Федосеев ГБ, Трофимов ВИ, Шапорова НЛ, Александрин ВА, Филиппова НА, Крякунов К.Н. В. поисках истины: что такое бронхиальная астма? Пульмонология. 2015;25:5-18
  99. Hogg JC. A brief review of chronic obstructive pulmonary disease. Canadian Respiratory Journal. 2012;19:381-384.
  100. Fletcher C., Peto R. The natural history of chronic airflow obstruction. British Medical Journal. 1977;1:1645-1648.
  101. Wang L., Hao K., Yang T., Wang C. Role of the lung microbiome in the pathogenesis of chronic obstructive pulmonary disease. Chin Med J. (Eng.). 2017;130:2107-2111. DOI: 10.4103366-6999.211452.
  102. King P., Sharma R. The lung immune response to nontypeable Haemophilus influenzae (Lung immunity to NTHi). J. Immunol Res. 2015. doi: 10.1155/2015/706736.
  103. Rossel A., Monso E., Soler N., Torres F., Angrill J., Riise G. et al. Microbiologic of exacerbation in chronic obstructive pulmonary disease. Arch Intern Med. 2005;165:891-897.
  104. King PT, MacDonald M., Bardin PG. Bacteria in COPD; their potential role and treatment. Transl Respir Med. 2013;1:13. DOI: org/10.1187/2213-0802-1-13.
  105. Monso E. Microbiome in chronic obstructive pulmonary disease. Annals Trans Med. 2017;5(12). DOI: 10.21037/ atm.2017.04.20.
  106. Groutas W., Dou D., Allison KR. Neutrophil elastase inhibitors. Expert Open The Pat. 2011;21:339-354.
  107. Finkelstein R., Flaser RS, Ghezzo MG, Cosio VG. Alveolar inflammation and its relation to emphysema in smokers. Am J. Respir Crit Care Med. 1998;152:1666-1672.
  108. Owen CA. Roles of proteinases in pathogenesis of chronic obstructive pulmonary disease. Intl J. COPD. 2008;3:253-268.
  109. Федосеев ГБ, Трофимов ВИ, Негруца КВ, Тимчик ВГ, Голубева ВИ, Александрин ВС и соавт. Что такое Overlap синдром (ACOS), диагностика и лечение. Российский Аллергологический Журнал. 2018;15:17-29
  110. Федосеев ГБ, Трофимов ВИ, Тимчик ВГ, Негруца КВ, Голубева ВИ, Горовнева ЕВ и соавт. Инфекционная и неинфекционная сенсибилизация больных бронхиальной астмой и хронической обструктивной болезнью легких. Российский Аллергологический Журнал. 2015;6:39-53
  111. McIvor RA Emerging therapeutic options for the treatment of patients with symptomatic asthma. Annals Allergy Asthma Immunol. 2015;115:265-271.
  112. Lommatzsch M., Virchow C. Severe Asthma: Definition, Diagnosis and Treatment. Dtsch Arztebl. 2014;111:847-855.
  113. Федосеев ГБ, Трофимов ВИ, Петрова М.А. Многоликая бронхиальная астма. СПб., Нордмедиздат. 2011:343
  114. Gold, 2017. Arch. Bronchopneumol. 2017;53:128-149.
  115. Which asthma patients should get the pneumococcal vaccine? J Fam Pract. 2009;58:611-612.
  116. Talbot TR, Harlert TV, Mitchel E, Halasa NB, Arbogast PG, Poehling KA et al. Asthma as a risk factor for invasivt pneumococcal disase. New Engl J Med. 2005;352:2082-2090.
  117. Streptococcas colonization in children and adolescents with asthma: impact of the heptavalent pneumococcal conjugate vaccine and evaluation of potential effect of thirteen-valent pneumococcal conjugate vaccine. BMC Infections Diseases. 2016;16:12-26.
  118. NewsonL.2017.https://translate googleusercontent.com/ translate_c?вузер=1&h1=ru&prev=search&rur.
  119. Froes F, Roche N, Blasi F. Pneumococcal vactination and chronic respiratory diseases. Int J of COPD. 2017;12:3457-3468.
  120. Earl CS, Shi-qi An, Ryan RP The changing face of asthma and its relation with microbes. Trends Microbiol. 2015;23:408-418.
  121. Sokolowska M, Frei R, Lunjanj N, Acdis CA, Mahony L. Microbiome and asthma. Asthma Res Pract. 2018;4:1. doi: 10.1186/s40733-017-0037y.
  122. Bieber T, Akdis C, Lauener R, Traidl-Hoffmann C, Scmid-Grendelmeier P, Schappi G et al. Global allergy forum and 3rd Davos declaration 2015: atopic dermatitis/eczema: challenges and opportunities toward precision medicine. Allergy. 2016;71:588-592. doi: 10.1111/all.12857.
  123. Lee SC, Yang YH, Huang SY Pan WH. Reduced medication use and improved pulmonary function with supplements containing vegetable and fruit concentrate, fish oil and probiotics in asthmatic school children a randomized controlled trial. Br J Nutr. 2013;110:145-155.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright © Pharmarus Print Media, 2018



This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies